HOLKIRA PAK
HOLKIRA PAK
Discontinued
DIN Number
02436027
Drug Class
Human
Market Date
Jan 6, 2015
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02436027
AIG Number0456390001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AP52 DASABUVIR, OMBITASVIR, PARITAPREVIR AND RITONAVIR
Product Specifications
Dosage FormKit
,
Tablet
Route of AdministrationOral
AHFS Classification08:18.40.20
Health Canada Classification
ACTIVE INGREDIENTS (4)
DASABUVIR (DASABUVIR SODIUM MONOHYDRATE)Active
Strength: 250 MG
Monograph: DASABUVIR (DASABUVIR SODIUM MONOHYDRATE)
OMBITASVIRActive
Strength: 12.5 MG
Monograph: OMBITASVIR
PARITAPREVIRActive
Strength: 75 MG
Monograph: PARITAPREVIR
RITONAVIRActive
Strength: 50 MG
Monograph: RITONAVIR